A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born

Stock Information for The9 Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About The9 Limited

The9 Establishes Joint Venture to Operate AI Algorithms Marketing Business
Zhejiang Huanyu and The9 Establish Joint Venture and Signed Non-Exclusive Agreement to Operate New MIR Game with Annual Revenue Commitment of RMB600 Million, Profit Commitment of RMB200 Million and Annual Increase of 30%
The9 Obtained Strategic Investment from Fine Vision Game Fund
The9 Obtained Exclusive Publishing License of "MIR M" IP, A New Chinese Edition of Mobile and PC Game from Wemade
The9 Signed a Definitive Share Purchase Agreement to Invest in AI Unmanned Retail Store Platform KuaiJin
The9 Limited Achieved 66% Increase in Net Revenues and Turned Net Loss into Net Income for the Year Ended December 31, 2023
/C O R R E C T I O N -- The9 Limited/
The9 Signed a Definitive Share Purchase Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.